# New York Blood Center, Inc. – FDA Inspection, Jun 6, 2016

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/070e4193-94b1-4f64-b92c-4a30d6722107
Source feed: FDA_Inspections

> FDA inspection 972369 of New York Blood Center, Inc., June 06, 2016. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 972369
- Company Name: New York Blood Center, Inc.
- Inspection Date: 2016-06-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1323326 - 2026-06-23](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/a435ca70-f990-4a17-851b-842569777d9e)
- FDA Inspection 1196752 - 2023-02-03
- FDA Inspection 1064470 - 2018-08-06
- FDA Inspection 891886 - 2014-08-08
- FDA Inspection 798581 - 2012-09-14

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/cfc7ef65-4248-4606-833d-2b72f6927618

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
